Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

AVDL holding history

Avadel Pharmaceuticals PLC in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of AVDL by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−770,232−100.0%Sold outHolders
Q4 2025770,232$16.6M<0.1%−287,654−27.2%ReducedHolders
Q3 20251,057,886$16.2M<0.1%−470,431−30.8%ReducedHolders
Q2 20251,528,317$13.5M<0.1%−716,693−31.9%ReducedHolders
Q1 20252,245,010$17.6M<0.1%−348,528−13.4%ReducedHolders
Q4 20242,593,538$27.3M<0.1%+234,992+10.0%AddedHolders
Q3 20242,358,546$30.9M<0.1%+117,265+5.2%AddedHolders
Q2 20242,241,281$31.5M<0.1%+677,391+43.3%AddedHolders
Q1 20241,563,890$26.4M<0.1%+950,705+155.0%AddedHolders
Q4 2023613,185$8.66M<0.1%+150,080+32.4%AddedHolders
Q3 2023463,105$4.77M<0.1%−23,090−4.7%ReducedHolders
Q2 2023486,195$8.01M<0.1%+167,714+52.7%AddedHolders
Q1 2023318,481$2.92M<0.1%+218,484+218.5%AddedHolders
Q4 202299,997$716.0K<0.1%+10,677+12.0%AddedHolders
Q3 202289,320$447.0K<0.1%−71,742−44.5%ReducedHolders
Q2 2022161,062$393.0K<0.1%+74,365+85.8%AddedHolders
Q1 202286,697$592.0K<0.1%−34,679−28.6%ReducedHolders
Q4 2021121,376$981.0K<0.1%+32,589+36.7%AddedHolders
Q3 202188,787$870.0K<0.1%−25,522−22.3%ReducedHolders
Q2 2021114,309$770.0K<0.1%+1,142+1.0%AddedHolders
Q1 2021113,167$1.02M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.